Correlation Between Denali Therapeutics and Painreform

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Painreform at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Painreform into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Painreform, you can compare the effects of market volatilities on Denali Therapeutics and Painreform and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Painreform. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Painreform.

Diversification Opportunities for Denali Therapeutics and Painreform

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Denali and Painreform is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Painreform in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Painreform and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Painreform. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Painreform has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Painreform go up and down completely randomly.

Pair Corralation between Denali Therapeutics and Painreform

Given the investment horizon of 90 days Denali Therapeutics is expected to generate 0.35 times more return on investment than Painreform. However, Denali Therapeutics is 2.9 times less risky than Painreform. It trades about 0.04 of its potential returns per unit of risk. Painreform is currently generating about -0.34 per unit of risk. If you would invest  2,149  in Denali Therapeutics on October 20, 2024 and sell it today you would earn a total of  44.00  from holding Denali Therapeutics or generate 2.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Denali Therapeutics  vs.  Painreform

 Performance 
       Timeline  
Denali Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Denali Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in February 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Painreform 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Painreform are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical and fundamental indicators, Painreform showed solid returns over the last few months and may actually be approaching a breakup point.

Denali Therapeutics and Painreform Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Denali Therapeutics and Painreform

The main advantage of trading using opposite Denali Therapeutics and Painreform positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Painreform can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Painreform will offset losses from the drop in Painreform's long position.
The idea behind Denali Therapeutics and Painreform pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets